Iodixanol supplementation during sperm cryopreservation improves protamine level and reduces reactive oxygen species of canine sperm

J Vet Sci. 2019 Jan 31;20(1):79-86. doi: 10.4142/jvs.2019.20.1.79.

Abstract

The objective of this study was to analyze the protective effects of iodixanol on dog spermatozoa during cryopreservation. The optimal concentration of iodixanol, 1.5%, was determined using fresh spermatozoa and was applied in the following experiments. The 1.5% iodixanol group showed significantly increased sperm motility from that in the control (p < 0.05). Lower mitochondrial reactive oxygen species (ROS) modulator (ROMO1) and pro-apoptotic gene (BAX) expressions, together with higher expressions of protamine-2 (PRM2), protamine-3 (PRM3), anti-apoptotic B-cell lymphoma-2 (BCL2), and sperm acrosome associated-3 (SPACA3) genes were detected in the iodixanol-treated group. In addition, decreased protamine deficiency and cryocapacitation were observed in the treatment group. Our results show that supplementation with 1.5% iodixanol is ideal for reducing production of ROS and preventing detrimental effects during the canine sperm cryopreservation process, effects manifested as increased motility and reduced cryocapacitation in frozen-thawed spermatozoa.

Keywords: Cryopreservation; Dogs; Protamine; Reactive oxygen species; Sperm.

MeSH terms

  • Animals
  • Cryopreservation / veterinary*
  • DNA Damage / drug effects*
  • Dogs
  • Dose-Response Relationship, Drug
  • Male
  • Protamines / metabolism*
  • Protective Agents / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Semen Preservation / veterinary*
  • Spermatozoa / drug effects
  • Spermatozoa / physiology*
  • Triiodobenzoic Acids / pharmacology*

Substances

  • Protamines
  • Protective Agents
  • Reactive Oxygen Species
  • Triiodobenzoic Acids
  • iodixanol